Prolastin aerosol therapy and sputum taurine in cystic fibrosis

Clinical and Investigative Medicine

Volumn 29, Issue 4, 2006, Pages 201-207

  Cantin, André M ^a   Berthiaume, Yves ^b   Cloutier, Diane ^a   Martel, Marc ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; TAURINE;

ADOLESCENT; ADULT; AEROSOL; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG SPUTUM LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG DISEASE; LUNG FUNCTION; MALE; NEUTROPHIL; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; SPUTUM; TAURINE;

EID: 33748556522     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34:91-100
2. Gibson RL, Emerson J, McNamara S, et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003; 167:841-849
3. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999; 340:23-30
4. Regelmann WE, Elliott GR, Warwick WJ, et al. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 1990; 141:914-921
5. Konstan MW, Hilliard KA, Norvell TM, et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation [published erratum appears in Am J Respir Crit Care Med 1995 Jan;151(1):260]. Am J Respir Crit Care Med 1994; 150:448-454
6. Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990; 86:300-308
7. Berger M, Sorensen RU, Tosi MF, et al. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989; 84:1302-1313
8. Birrer P. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies. Respiration 1995; 62:25-28
9. Vogelmeier C, Kirlath I, Warrington S, et al. The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers. Am J Respir Crit Care Med 1997; 155:536-541
10. McElvaney NG, Hubbard RC, Birrer P, et al. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 1991; 337:392-394
11. Cantin AM. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J Clin Invest 1994; 93:606-614
12. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996; 154:1229-1256
13. Cantin AM. DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice. Am J Respir Crit Care Med 1998; 157:464-469
14. Cantin AM, Lafrenaye S, Begin RO. Antineutrophil elastase activity in cystic fibrosis serum. Pediatr Pulmonol 1991; 11:249-253
15. Cantin AM, Woods DE. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 1999; 160:1130-1135
16. Bruce MC, Poncz L, Klinger JD, et al. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985; 132:529-535.
17. Jackson AH, Hul SL, Afford SC, et al. Sputum solphase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis 1984; 65:114-124
18. Suter S, Schaad UB, Roux L, et al. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis 1984; 149:523-531
19. Suter S, Schaad UB, Tegner H, et al. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis 1986; 153:902-909
20. Fick RB, Jr., Baltimore RS, Squier SU, et al. IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. J Infect Dis 1985; 151:589-598
21. Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, et al. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol 1999; 20:729-736
22. Stockley RA. Role of inflammation in respiratory tract infections. Am J Med 1995; 99:8S-13S.
23. Reeves EP, Lu H, Jacobs HL, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416:291-297
24. Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998; 4:615-618
25. Belaaouaj A, Kim KS, Shapiro SD. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science 2000; 289:1185-1188
26. Lopez-Boado YS, Espinola M, Bahr S, et al. Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity. J Immunol 2004; 172:509-515
27. Taggart C, Cervantes-Laurean D, Kim G, et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 2000; 275:27258-27265
28. Cantin AM, Woods DE, Cloutier D, et al. Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha 1 proteinase inhibitor. Am J Respir Cell Mol Biol 2002; 27:659-665
29. Rees DD, Brain JD, Wohl ME, et al. Inhibition of neutrophil elastase in CF sputum by L-658,758. J Pharmacol Exp Ther 1997; 283:1201-1206
30. Rees DD, Rogers RA, Cooley J, et al. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 1999; 20:69-78
31. Cantin AM, Woods DE, Cloutier D, et al. Leukocyte elastase inhibition therapy in cystic fibrosis: role of glycosylation on the distribution of alpha-1-proteinase inhibitor in blood versus lung. J Aerosol Med 2002; 15:141-148
32. Delacourt C, Herigault S, Delclaux C, et al. Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor. Am J Respir Cell Mol Biol 2002; 26:290-297